Skip to main content
Log in

Comment on: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”

  • Letter to the Editor
  • Published:
American Journal of Cardiovascular Drugs Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 18 May 2017

The Original Article was published on 28 March 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Thomas D, Ali Z, Zachariah S, et al. Coxibs refocus attention on the cardiovascular risks of non-aspirin NSAIDs. Am J Cardiovasc Drugs (Epub 28 Mar 2017). doi:10.1007/s40256-017-0223-6

  2. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29.

    Article  CAS  PubMed  Google Scholar 

  3. Protocol for: Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29. doi:10.1056/NEJMoa1611593

  4. Supplement to: Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29. doi:10.1056/NEJMoa1611593

  5. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–79.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin A. Urtasun.

Ethics declarations

Funding

No sources of funding were used to assist with the preparation of this manuscript.

Conflict of interest

Drs. Urtasun, Prozzi, Marín, Buschiazzo, Cañás, Dorati, and Mordujovich have no potential conflicts of interest that might be relevant to the content of this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Urtasun, M.A., Prozzi, G.R., Marín, G.H. et al. Comment on: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”. Am J Cardiovasc Drugs 17, 493–495 (2017). https://doi.org/10.1007/s40256-017-0235-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40256-017-0235-2

Navigation